Literature DB >> 2403346

Regiospecificity in the hydroxylation of lauric acid by rainbow trout hepatic cytochrome P450 isozymes.

C L Miranda1, J L Wang, M C Henderson, D E Williams, D R Buhler.   

Abstract

The catalytic activity of two hepatic cytochrome P450 isozymes from untreated rainbow trout towards lauric acid was investigated. In a reconstituted system, cytochrome P450 LMC1 and P450 LMC2 were found to catalyze exclusively the omega- and (omega-1)-hydroxylation of lauric acid, respectively. Microsomal enzyme inhibition studies with polyclonal antibodies raised against the individual P450 isozymes showed that P450 LMC1 and LMC2, respectively, accounted for most if not all the omega- and (omega-1)-lauric acid hydroxylase activity of trout liver microsomes. The polyclonal antibodies were highly specific in that they only inhibited the enzyme activity of the P450 used as the immunogen. These results illustrate that as in mammals, omega- and (omega-1)-hydroxylation of lauric acid by trout liver microsomes can be carried out separately by distinct isozymes of cytochrome P450.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403346     DOI: 10.1016/0006-291x(90)91179-v

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Subterminal hydroxylation of lauric acid by microsomes from a marine fish.

Authors:  P Lemaire; M Lafaurie; D Weissbart; F Durst; P Pflieger; C Mioskowski; J P Salaün
Journal:  Lipids       Date:  1992-03       Impact factor: 1.880

2.  Effects of salinity acclimation on the expression and activity of Phase I enzymes (CYP450 and FMOs) in coho salmon (Oncorhynchus kisutch).

Authors:  Ramon Lavado; Rosaura Aparicio-Fabre; Daniel Schlenk
Journal:  Fish Physiol Biochem       Date:  2013-08-08       Impact factor: 2.794

Review 3.  Fish models for environmental carcinogenesis: the rainbow trout.

Authors:  G S Bailey; D E Williams; J D Hendricks
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.